These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 9549732

  • 1. Local expression of cytokines in idiopathic inflammatory myopathies.
    Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF.
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):73-9. PubMed ID: 9549732
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM, Reed AM.
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [Abstract] [Full Text] [Related]

  • 3. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
    Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L.
    Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
    [Abstract] [Full Text] [Related]

  • 4. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O, Squier W, Boyer O, Hilton-Jones D, Herson S.
    Presse Med; 2004 Nov 20; 33(20):1444-50. PubMed ID: 15611679
    [Abstract] [Full Text] [Related]

  • 5. CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies.
    Bartoli C, Civatte M, Pellissier JF, Figarella-Branger D.
    Acta Neuropathol; 2001 Oct 20; 102(4):385-92. PubMed ID: 11603815
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features.
    Mantegazza R, Bernasconi P, Confalonieri P, Cornelio F.
    J Neurol; 1997 May 20; 244(5):277-87. PubMed ID: 9178151
    [Abstract] [Full Text] [Related]

  • 7. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B, Creus KK, De Bleecker JL.
    Curr Opin Rheumatol; 2009 Nov 20; 21(6):610-6. PubMed ID: 19726994
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA.
    Folia Med (Plovdiv); 2017 Mar 01; 59(1):7-13. PubMed ID: 28384112
    [Abstract] [Full Text] [Related]

  • 9. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D, Schleinitz N, Boutière-Albanèse B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF, Dignat-George F.
    J Rheumatol; 2006 Aug 01; 33(8):1623-30. PubMed ID: 16881117
    [Abstract] [Full Text] [Related]

  • 10. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L, Blumbergs PC, Manavis J, Limaye VS.
    Appl Immunohistochem Mol Morphol; 2013 Dec 01; 21(6):539-42. PubMed ID: 23343957
    [Abstract] [Full Text] [Related]

  • 11. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.
    J Neurol; 2002 Jan 01; 249(1):69-75. PubMed ID: 11954871
    [Abstract] [Full Text] [Related]

  • 12. Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy.
    Megens-de Letter MA, Visser LH, van Doorn PA, Savelkoul HF.
    Eur Cytokine Netw; 1999 Dec 01; 10(4):471-8. PubMed ID: 10586113
    [Abstract] [Full Text] [Related]

  • 13. New developments in the role of cytokines and chemokines in inflammatory myopathies.
    Lundberg IE, Nyberg P.
    Curr Opin Rheumatol; 1998 Nov 01; 10(6):521-9. PubMed ID: 9812212
    [Abstract] [Full Text] [Related]

  • 14. Idiopathic inflammatory myopathies.
    Dimachkie MM.
    J Neuroimmunol; 2011 Feb 01; 231(1-2):32-42. PubMed ID: 21093064
    [Abstract] [Full Text] [Related]

  • 15. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
    Gherardi RK.
    Presse Med; 2011 Apr 01; 40(4 Pt 2):e209-18. PubMed ID: 21376512
    [Abstract] [Full Text] [Related]

  • 16. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A.
    Curr Opin Rheumatol; 2011 Nov 01; 23(6):595-604. PubMed ID: 21934500
    [Abstract] [Full Text] [Related]

  • 17. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
    De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL.
    Ann N Y Acad Sci; 2009 Sep 01; 1173():463-9. PubMed ID: 19758187
    [Abstract] [Full Text] [Related]

  • 18. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J, Lilleker JB, Parker M, McHugh N, Chinoy H.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):3398-3403. PubMed ID: 33367878
    [Abstract] [Full Text] [Related]

  • 19. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.
    Lundberg IE.
    Curr Rheumatol Rep; 2000 Jun 01; 2(3):216-24. PubMed ID: 11123062
    [Abstract] [Full Text] [Related]

  • 20. Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.
    O'Hanlon TP, Messersmith WA, Dalakas MC, Plotz PH, Miller FW.
    Clin Exp Immunol; 1995 Jun 01; 100(3):519-28. PubMed ID: 7774065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.